Biotech of the week: Enterome, the Leading French Microbiome Start-up

09/10/2015 - 2 minutes

enterome bioscience logo

This week we’ve left the sunny Portuguese coast behind us and arrived in the ‘City of Lights’, Paris. The capital city of France is famous for the Eiffel Tower, fashion and cuisine but what you may not know it is home to Enterome Bioscience, a pioneer in personalized therapies that focus on microbiome related diseases.

 

City: Paris, France

Founded: 2012

Money Raised: €17.5m (as of 10/2015)

Employees: 10 (as of 03/2015)

CEO:

Mission: Enterome bioscience is a private company based in Paris, France. Their goal is to develop innovative therapeutic solutions in the novel field of diseases associated with gut microbiome abnormalities. Enterome have been at the forefront of the effects of gut microbiota in health and disease and have achieved this by using 2 different metagenomic platforms. The first, quantitative, allows them to isolate the bacteria of interest which could be linked to a disease and the second, functional, allows the discovery and development of new drugs to combat these diseases. 

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member